David Hochman is Chief Executive Officer & Chairman of Orchestra BioMed Holdings, Inc. (OBIO). The company reported total compensation of $2,261,233 for fiscal year 2025.
| Salary | $595,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $791,399 |
| Option awards | $290,575 |
| Non-equity incentive plan | $572,009 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $12,250 |
| Total | $2,261,233 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Orchestra BioMed Holdings, Inc. filed April 29, 2026, accession 0001104659-26-051570.
| Peer-group chief executive median | $3,843,396 |
|---|---|
| Difference from that median | $-1,582,162 |
| Percentile within the disclosed peer group | 20th |
| Peers with a disclosed figure | 10 |
Medians and percentiles are computed across the peer group Orchestra BioMed Holdings, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Hochman this page | Chief Executive Officer & Chairman | $2,261,233 |
| Darren Sherman | President & Chief Operating Officer | $1,757,835 |
| Andrew Taylor | Chief Financial Officer | $1,206,517 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Orchestra BioMed Holdings, Inc. compensation brief.
David Hochman's compensation sits inside Orchestra BioMed Holdings, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Orchestra BioMed Holdings, Inc. (OBIO) compensation brief